Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2613 | None - NA Wiki | 1.00 |
| drug2395 | Mindfulness training Wiki | 1.00 |
| drug2880 | Personalized ambulatory training Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D004932 | Esophageal and Gastric Varices NIH | 1.00 |
| D003108 | Colonic Diseases NIH | 1.00 |
| D005764 | Gastroesophageal Reflux NIH | 0.71 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0002040 | Esophageal varix HPO | 1.00 |
| HP:0002020 | Gastroesophageal reflux HPO | 0.71 |
Navigate: Correlations HPO
There is one clinical trial.
COVID19 patients survivors, after discharge from hospital show reduced lung function and reduced ability to exercise. Furthermore, mental health problems including stress, anxiety and depression and a low quality of life were observed. The prospective observational study involves COVID19 patients who have needed rehabilitation at the University Hospital of Ferrara. Patients receive comprehensive rehabilitation based on their specific needs in both acute and subacute rehabilitation. At the end of hospital rehabilitation, patients are offered a program to be carried out at home for both physical and psychological problems. A range of demographic and clinical data will be collected. Patients will also undergo a battery of functional, cognitive and psychological tests during the hospital rehabilitation period and after 6, 12 and 26 weeks.
Description: Rating perceived exertion
Measure: Borg scale Time: At the beginning of early rehabilitationDescription: Heart rate in sitting and standing positions.
Measure: Heart rate Time: At the beginning of early rehabilitationDescription: Oxygen saturation in sitting and standing positions.
Measure: Oxygen saturation Time: At the beginning of early rehabilitationDescription: To measure the strength of the lower limbs.
Measure: 30 seconds sit-to-stand test Time: At the beginning of early rehabilitationDescription: To measure the strength of the lower limbs.
Measure: Change in 1 minute sit-to-stand test between two time points Time: Month 3, Month 6Description: Is a general health questionnaire for the assessment of the patient's quality of life. Two summary scores are reported: a mental component score and a physical component score. The scores may be reported as Z-scores.
Measure: Change in Short form health survey between three time points Time: At the beginning of early rehabilitation, Month 3, Month 6Description: For mobility assessment
Measure: 2-minute walking test Time: At the beginning of early rehabilitationDescription: For mobility assessment
Measure: Change in 6-minute walking test between two time points Time: Month 3, Month 6Description: Evaluate the functional autonomy of the patient both on the motor and cognitive side (minumum score:18 maximum score:126 ). At 3 months the "FIM efficiency" is evaluated as a measure of the efficiency of the rehabilitation intervention.
Measure: Change in Functional Independence Measure Scale between two time points Time: At the beginning of early rehabilitation, Month 3Description: Cognitive screening test
Measure: Change in Montreal Cognitive Assessment between two time points Time: Month 3, Month 6Description: For measuring cognitive reserve
Measure: Cognitive Reserve Index questionnaire Time: Month 3Description: To identify the presence of depression and measure its severity
Measure: Change in Patient Health Questionnaire-9 between two time points Time: Month 3, Month 6Description: To measure the severity of anxiety
Measure: Change in Beck anxiety inventory between two time points Time: Month 3, Month 6Description: To measure the resilience
Measure: Change in Connor-Davidson Resilience Scale between two time points Time: Month 3, Month 6Description: To measure the amount of distress that associate with a specific event.
Measure: Change in Impact of Event Scale - Revised between two time points Time: Month 3, Month 6Description: To assess how much people believe they can achieve their goals, despite difficulties
Measure: Change in General Self Efficacy Scale between two time points Time: Month 3, Month 6Description: To assess sleep quality
Measure: Change in Pittsburgh Sleep Quality Index between two time points Time: Month 3, Month 6Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports